Ajanta Pharma Limited — Others, 27-12-2024: Trading Window

Ajanta Pharma Limited has announced a board meeting on the closure of the trading window for its securities, effective from the end of business hours on December 31, 2024, until 48 hours post the declaration of financial results for the quarter and nine months. This move is standard practice to prevent insider trading ahead of financial disclosures. Investors should see this as a standard compliance measure, with a neutral impact on sentiment until further financial results provide clarity on company performance and strategy moving forward.